Utilisation de la prévention des TMS pour un changement culturel dans l’exploitation minière: partenariat entre le gouvernement du Queensland et l’Anglo Coal Industry.

Queensland Mining places a strong emphasis on safety performance, but managing health risks, including musculoskeletal disorders (MSDs), continues to have a lower priority. The use of individual worker screening and lower level approaches such as manual handling training are part of the coal mining ‘culture’. Initiatives such as the New South Wales and Queensland Mining joint project to develop good practice guidelines for mining have helped to spread a more consistent message on participatory ergonomics and MSD prevention. A practical, evidence-based approach, including the introduction of participatory ergonomics and safe design principles, was offered for Anglo American Coal operations in Queensland.

The project consisted of an analysis of the skills of current health workers, the design of a facilitated participatory ergonomics training program, site visits to identify good practices and champions, and a graduated mentoring program for the personal health. Initial results show that a number of sites benefit from site working groups focused on positive performance results. and a graduated mentoring program for health workers. Initial results show that a number of sites benefit from site working groups focused on positive performance results. and a graduated mentoring program for health workers. Initial results show that a number of sites benefit from site working groups focused on positive performance results.

Prevention of MSDs through an ergonomic risk assessment (tools) in all phases of the vehicle development process.

In industrialized countries, musculoskeletal disorders (MSDs) play an important role and are often responsible for almost a third of all sick leaves. Changing demographic profiles, i.e. the aging of the workforce, could even worsen this situation in the future. For a highly productive and sustainable use of human resources in production systems, ergonomics offers high potential. In recent years, the authors have developed several ergonomic risk assessment tools, particularly for use in automotive industries. These methods can be used during the planning phases in Tech Centers as well as during the production phase at the shop floor.

The tools could also be used for standardized communication between the Tech Center and factories to improve the effects of “lessons learned” for the design and layout of workstations and processes and the optimization of vehicle components. . This article describes the appropriate risk assessment tools as well as the integration of these tools into the vehicle development process. It introduces a global management approach for the integration of ergonomics in the management of production systems. optimization of vehicle components.

This article describes the appropriate risk assessment tools as well as the integration of these tools into the vehicle development process. It introduces a global management approach for the integration of ergonomics in the management of production systems. optimization of vehicle components. This article describes the appropriate risk assessment tools as well as the integration of these tools into the vehicle development process. It introduces a global management approach for the integration of ergonomics in the management of production systems.

Innovation in the profession of occupational physician requires the development of a working group to improve the effectiveness of MSD prevention.

Given the aging population of occupational physicians and the deterioration in the health of employees, reforms aimed at the multidisciplinary nature of occupational health are being drawn up. These are of great concern to physicians with regard to the future of occupational health, especially with regard to the evolution of medical practices. The objective of this study is to explore the actual practices of occupational physicians in the context of the prevention of MSDs in France. By analyzing the activity of occupational physicians, we could better understand the coordination between OSH actors with the ultimate goal of improving prevention.

Utilisation de la prévention des TMS pour un changement culturel dans l'exploitation minière: partenariat entre le gouvernement du Queensland et l'Anglo Coal Industry.

Based on an analysis of peer activity, this method made it possible to go beyond the pre-constructed discourse. According to the theories of activity, it is through others that the history and controversies of a profession can be understood and skills developed. The results produced by these collective discussions on the analysis of activities helped to establish a collective point of view on the important aspects of their profession to be defended and the variations of professional gender in relation to the current reforms, in particular.

Multiple sclerosis documentation system (MSDS): moving from documentation to the management of patients with MS.

The long duration of multiple sclerosis disease and the increasing treatment options require an individualized therapeutic approach that must be carefully documented over years of observation. To move from MS documentation to innovative MS management, new IT and Internet tools could be implemented, as we have been able to demonstrate with the new patient management IT system “Multiple Sclerosis Management System 3D ”(MSDS 3D). MSDS 3D allows the documentation and management of visiting schedules and compulsory examinations via study modules defined by the integration of input data from various sources (patients, treating physicians and MS nurses).

It provides forms for documenting patient visits as well as clinical and diagnostic results. Information can be collected through interactive touch screens. Specific modules allow the management of highly effective treatments such as natalizumab or fingolimod. The MSDS can be used to transfer documented data to databases such as e.g. the register of the German company MS or REGIMS. The MSDS has already been successfully implemented in clinical practice and is currently being evaluated in a multi-center environment. High quality management and documentation are essential to improve clinical practice and research.

Information can be collected through interactive touch screens. Specific modules allow the management of highly effective treatments such as natalizumab or fingolimod. The MSDS can be used to transfer documented data to databases such as e.g. the register of the German company MS or REGIMS. The MSDS has already been successfully implemented in clinical practice and is currently being evaluated in a multi-center environment. High quality management and documentation are essential to improve clinical practice and research. Information can be collected through interactive touch screens.

Specific modules allow the management of highly effective treatments such as natalizumab or fingolimod. The MSDS can be used to transfer documented data to databases such as e.g. the register of the German company MS or REGIMS. The MSDS has already been successfully implemented in clinical practice and is currently being evaluated in a multi-center environment. High quality management and documentation are essential to improve clinical practice and research. The MSDS can be used to transfer documented data to databases such as e.g. the register of the German company MS or REGIMS. The MSDS has already been successfully implemented in clinical practice and is currently being evaluated in a multi-center environment. High quality management and documentation are essential to improve clinical practice and research.

Chlorpyrifos antibody

70-1068 500 ul
EUR 349
Description: Rabbit polyclonal Chlorpyrifos antibody

Chlorpyrifos antibody

70-1070 500 ul
EUR 349
Description: Chicken polyclonal Chlorpyrifos antibody

Chlorpyrifos antibody

70-1071 50 ul
EUR 327
Description: Rabbit polyclonal Chlorpyrifos antibody

Chlorpyrifos [HRP]

DAGA-067H 1mg
EUR 1170

Chlorpyrifos [BSA]

DAGA-079B 1mg
EUR 780

Chlorpyrifos [KLH]

DAGA-085K 1mg
EUR 1040

Chlorpyrifos ELISA Kit

DEIANJ22 96T
EUR 866
Description: The Chlorpyrifos ELISA is an immunoassay for the detection of chlorpyrifos in contaminated samples.

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

Rabbit anti Bovine

E61I02501 0.1mg
EUR 343

UltraTek Anti-Rabbit

ABK008 8 ml
EUR 80

UltraTek Anti-Rabbit

ABK015 15 ml
EUR 98

UltraTek Anti-Rabbit

ABK125 125 ml
EUR 228

UltraTek Anti-Rabbit

ABK500 500 ml
EUR 554

UltraTek Anti-Rabbit

ABK999 1000 ml
EUR 934

SensiTek Anti-Rabbit

ABE008 8 ml
EUR 71

SensiTek Anti-Rabbit

ABE015 15 ml
EUR 80

SensiTek Anti-Rabbit

ABE125 125 ml
EUR 176

SensiTek Anti-Rabbit

ABE500 500 ml
EUR 420

SensiTek Anti-Rabbit

ABE999 1000 ml
EUR 711

Anti-Rabbit antibody

STJ11100323 100 µl
EUR 277

Polyclonal Rabbit Anti-HSA

C020101-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-HSA

C020101-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-BSA

C020102-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-BSA

C020102-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-HRP

C020103-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-HRP

C020103-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-OVA

C020105-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-OVA

C020105-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-FITC

C020115-10mg 10mg
EUR 3058

Polyclonal Rabbit Anti-FITC

C020115-1mg 1mg
EUR 523

Polyclonal Rabbit Anti-Biotin

C020116-10mg 10mg
EUR 3058

Polyclonal Rabbit Anti-Biotin

C020116-1mg 1mg
EUR 523

Polyclonal Rabbit Anti-SPA

C020117-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-SPA

C020117-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-SPG

C020118-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-SPG

C020118-1mg 1mg
EUR 201

Polyclonal Rabbit Anti-SA

C020120-10mg 10mg
EUR 861

Polyclonal Rabbit Anti-SA

C020120-1mg 1mg
EUR 201

Rabbit Anti Human IgG

E61I00101 100ug
EUR 343

Rabbit anti mouse IgG

E61I00901 100ug
EUR 343

Rabbit anti Sheep IgG

E61I01001 100ul
EUR 343

Rabbit anti Goat IgG

E61I01002 1mg
EUR 343

Rabbit anti RBC IgG

E61I01102 1mg
EUR 343

goat Anti Rabbit IgG

E61I01301 1mg
EUR 274

Rabbit Anti FITC Antibody

E61I01402 100ug
EUR 343

Rabbit anti Chicken IgY

E61I0201 100ug
EUR 343

Rabbit anti Pig IgG

E61I02301 0.1mg
EUR 343

Rabbit anti Horse IgG

E61I02401 0.1mg
EUR 343

Rabbit Anti-Glutathione IgG

GSH11-A 100 ul
EUR 482

Rabbit anti- mouse IgA

FNab09894 100µg
EUR 548.75
  • Recommended dilution: WB: 1:1000-1:10000
  • IHC: 1:2000-1:20000
  • Immunogen: mouse IgA
  • Research Area: Immunology
Description: Antibody raised against Rabbit mouse IgA

Rabbit Anti-Monkey IgG

FNSA-0099 500 uL
EUR 306.6
  • Suggested dilution: 1:2000-1:10000 for western blotting with ECL substrates1:1000-1:20000 for ELISA and Western blotting with chromogenic substrates
  • Stabilizer: 5mg/ml BSA ( IgG-Free, Protease-Free)
Description: Rabbit Anti-Monkey IgG secondary antibody

Goat anti Rabbit IgM

70R-IG009 1 mg
EUR 165
Description: Goat Purifed Secondary Antibodies Goat anti Rabbit IgM antibody

Rabbit anti Chicken IgG

41C-CB0315 2 mg
EUR 269
Description: Rabbit anti Chicken IgG secondary antibody

Rabbit anti Goat IgG

41C-CB0529 2 mg
EUR 244
Description: Rabbit anti Goat IgG secondary antibody

Goat anti Rabbit IgG

41C-CB1143 2 mg
EUR 278
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG

41C-CB1150 10 mg
EUR 388
Description: Goat anti Rabbit IgG secondary antibody

Rabbit anti Mouse IgG1

41C-CB5120 1 mg
EUR 311
Description: Rabbit anti Mouse IgG1 secondary antibody

Rabbit anti Mouse IgG2a

41C-CB5127 1 mg
EUR 311
Description: Rabbit anti Mouse IgG2a secondary antibody

Rabbit anti Mouse IgA

41C-CB5143 1 mg
EUR 360
Description: Rabbit anti Mouse IgA secondary antibody

Goat anti Rabbit IgG

41R-1079 2 mg
EUR 149
Description: Goat anti Rabbit IgG secondary antibody

Rabbit anti Bovine IgA

41R-RB001 1 mg
EUR 216
Description: Rabbit anti Bovine IgA secondary antibody

Mouse anti Rabbit IgG

40-1005 1 mg
EUR 349
Description: Mouse anti Rabbit IgG secondary antibody

Mouse anti Rabbit IgG

40-1006 1 mg
EUR 349
Description: Mouse anti Rabbit IgG secondary antibody

Rabbit anti Mouse IgM

40-B9201R000-R0 5 ml
EUR 133
Description: Rabbit anti Mouse IgM secondary antibody

Goat anti Rabbit IgG

40-GR30 100 ml
EUR 241
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG

40-GR30S 100 ml
EUR 133
Description: Goat anti Rabbit IgG secondary antibody

Rabbit anti Sheep IgG

40-RS50 100 ml
EUR 133
Description: Rabbit anti Sheep IgG secondary antibody

Sheep anti Rabbit IgG

40-SR35 250 ml
EUR 133
Description: Sheep anti Rabbit IgG secondary antibody

Rabbit anti Bovine IgG

40C-CB0115 2 mg
EUR 281
Description: Rabbit anti Bovine IgG secondary antibody

Rabbit anti Bovine IgG

40C-CB0129 5 mg
EUR 347
Description: Rabbit anti Bovine IgG secondary antibody

Rabbit anti Cat IgG

40C-CB0222 2 mg
EUR 248
Description: Rabbit anti Cat IgG secondary antibody

Rabbit anti Chicken IgG

40C-CB0322 5 mg
EUR 346
Description: Rabbit anti Chicken IgG secondary antibody

Rabbit anti Dog IgG

40C-CB0408 2 mg
EUR 273
Description: Rabbit anti Dog IgG secondary antibody

Rabbit anti Dog IgG

40C-CB0415 5 mg
EUR 347
Description: Rabbit anti Dog IgG secondary antibody

Rabbit anti Goat IgG

40C-CB0536 1.5 mg
EUR 269
Description: Rabbit anti Goat IgG secondary antibody

Rabbit anti Human IgG

40C-CB0943 1 mg
EUR 249
Description: Rabbit anti Human IgG secondary antibody

Rabbit anti Human IgG

40C-CB0950 5 mg
EUR 381
Description: Rabbit anti Human IgG secondary antibody

Rabbit anti Human IgG

40C-CB0971 2 mg
EUR 322
Description: Rabbit anti Human IgG secondary antibody

Goat anti Rabbit IgG

40C-CB1157 5 mg
EUR 311
Description: Goat anti Rabbit IgG secondary antibody

Rabbit anti Rat IgG

40C-CB1243 2 mg
EUR 262
Description: Rabbit anti Rat IgG secondary antibody

Rabbit anti Rat IgM

40C-CB1264 2 mg
EUR 285
Description: Rabbit anti Rat IgM secondary antibody

Rabbit anti Sheep IgG

40C-CB1329 500 µg
EUR 380
Description: Rabbit anti Sheep IgG secondary antibody

Rabbit anti Sheep IgG

40C-CB1343 500 µg
EUR 358
Description: Rabbit anti Sheep IgG secondary antibody

Rabbit anti Mouse IgM

40C-CB1506 2 mg
EUR 284
Description: Rabbit anti Mouse IgM secondary antibody

Rabbit anti Mouse IgG2b

40C-CB5134 1 mg
EUR 340
Description: Rabbit anti Mouse IgG2b secondary antibody

Rabbit anti Mouse IgG3

40C-CB5141 1 mg
EUR 340
Description: Rabbit anti Mouse IgG3 secondary antibody

Rabbit anti Human IgM

40C-CB9100 2 mg
EUR 283
Description: Rabbit anti Human IgM secondary antibody

Rabbit anti Human IgA

40C-CB9114 2 mg
EUR 259
Description: Rabbit anti Human IgA secondary antibody

Rabbit anti Goat IgM

40R-1020 1 mg
EUR 219
Description: Goat anti Rabbit IgM secondary antibody

Rabbit anti Goat IgA

40R-1022 1 mg
EUR 241
Description: Rabbit anti Goat IgA Secondary Antibody

Rabbit anti Pig Serum

40R-RS001 2 ml
EUR 241
Description: Rabbit anti Pig Serum antibody

Goat anti Rabbit IgG

41-GR30 10 mg
EUR 277
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG

41-GR31 5 mg
EUR 162
Description: Goat anti Rabbit IgG secondary antibody

Rabbit anti Sheep IgG

41-RS45 2 mg
EUR 273
Description: Rabbit anti Sheep IgG secondary antibody

Rabbit anti-Vaccinia antiserum

01-0003 250uL
EUR 451
Description:
  • Related to: Other Viruses
  • Applications: ELISA, WB

Rabbit anti-Junin antiserum

01-0006 250uL
EUR 451
Description:
  • Related to: Other Viruses
  • Applications: ELISA, WB

Rabbit anti-LukA pAb

0316-001 100ug
EUR 354
Description:
  • Related to: Staphylococcus
  • Applications: ELISA, WB

Rabbit anti-LukB pAb

0317-001 100ug
EUR 354
Description:
  • Related to: Staphylococcus
  • Applications: ELISA, WB

Rabbit anti-Junin pAb

04-0006 500ug
EUR 257
Description:
  • Related to: Other Viruses
  • Applications: ELISA, WB

Rabbit anti-Hla pAb

04-0010 500ug
EUR 303
Description:
  • Related to: Staphylococcus
  • Applications: ELISA, WB

Rabbit anti Mouse IgM

20-B80010000-U4 10 ml
EUR 192
Description: Rabbit anti Mouse IgM antibody

Rabbit anti Chicken IgY

20-B9093R000-R0 5 ml
EUR 138
Description: Rabbit anti Chicken IgY antibody

Rabbit anti Human IgE

20-IR77 1 ml
EUR 192
Description: Rabbit anti Human IgE antibody

Rabbit anti Goat IgG

20-S5801R000-VO 10 ml
EUR 133
Description: Rabbit anti Goat IgG antibody

Polyclonal Rabbit anti-GAPDH

DRD96417 50 uL
EUR 280

Rabbit Anti-mPEG antiserum

PEG11-S 100 ul
EUR 408

Rabbit Anti-Phosphotyrosine antiserum

PTYR11-S 100 ul
EUR 457

Rabbit anti- mouse IgA

LSMab09894 100 ug
EUR 386

Rabbit anti-SAM b

PA00201-100 100µg
EUR 738
Description: Rabbit polyclonal antibody to S-Adenosylmethionine

Rabbit anti-SAM a

PA00201-50 50µg
EUR 445
Description: Rabbit polyclonal antibody to S-Adenosylmethionine

Rabbit anti-MAT s

PA00401-50 50µg
EUR 221
Description: Rabbit polyclonal antiserum against methionine adenosyltransferase

Rabbit anti-MAT g

PA00402-50 50µg
EUR 221
Description: Rabbit polyclonal antiserum against methionine adenosyltransferase with glycerol

Rabbit Anti-Serotonin antiserum

SER21-S 100 ul
EUR 457

Anti-Rabbit IgG antibody

STJ99246 200 µl
EUR 197
Description: Mouse monoclonal to Rabbit IgG.

Polyclonal Rabbit anti-sEH

SEH-1 50 uL
EUR 280

Anti-Rabbit IgG antibody

STJ16101370 1 mg
EUR 214

Anti-Rabbit IgG antibody

STJ16101371 1.2 mg
EUR 257

Anti-Rabbit IgG antibody

STJ16101372 1.2 mg
EUR 306

Anti-Rabbit IgG antibody

STJ16101375 1 mg
EUR 538

Anti-CD63 Antibody (rabbit anti-human) with goat anti-rabbit HRP secondary antibody

EXOAB-CD63A-1 25 ul
EUR 219
  • Category: Exosomes

Anti-CD81 Antibody (rabbit anti-human) with goat anti-rabbit HRP secondary antibody

EXOAB-CD81A-1 25 ul
EUR 219
  • Category: Exosomes

Anti-CD9 Antibody (rabbit anti-human) with goat anti-rabbit HRP secondary antibody

EXOAB-CD9A-1 25 ul
EUR 219
  • Category: Exosomes

Anti-Hsp70 Antibody (rabbit anti-human) with goat anti-rabbit HRP secondary antibody

EXOAB-Hsp70A-1 25 ul
EUR 219
  • Category: Exosomes

Anti-Rabbit Anti-Goat Heavy Chain Antibody

STJ501160 100 µg
EUR 476

Anti-Rabbit Anti-Goat Light Chain Antibody

STJ501175 100 µg
EUR 476

Anti-ALIX Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-ALIX-1 25 ul
EUR 219

Anti-ANXA5 Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-ANXA5-1 25 ul
EUR 219

Anti-CXCR4 Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-CXCR4-1 25 ul
EUR 219

Anti-EpCam Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-EPCAM1-1 25 ul
EUR 219

Anti-FLOT1 Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-FLOT1-1 25 ul
EUR 219

Anti-TSG101 Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-TSG101-1 25 ul
EUR 219

Anti-Vimentin Antibody (rabbit anti-human, mouse, rat) with goat anti-rabbit HRP secondary antibody

EXOAB-VMTN-1 25 ul
EUR 219

Rabbit Anti-Rabbit SYN1 Polyclonal Antibody, Phospho-Ser9

CPB-795RH 100 ul
EUR 559

Rabbit Anti-Rabbit Th Polyclonal Antibody, Phospho-Ser19

CPB-840RR 100 ul
EUR 559

Rabbit Anti-Rabbit PIK3R1 Polyclonal Antibody, Phospho-Tyr467

CPB-847RH 100 ul
EUR 559

Rabbit Anti-Rabbit ERBB3 Polyclonal Antibody, Phospho-Tyr1328

CPB-848RH 100 ul
EUR 559

Rabbit Anti-Rabbit EIF4G1 Polyclonal Antibody, Phospho-Ser1232

CPB-851RH 100 ul
EUR 559

Rabbit Anti-Rabbit PDK1 Polyclonal Antibody, Ab-241

CPB-921RH 100 ul
EUR 460

Rabbit Anti-Rabbit GSK3A Polyclonal Antibody, Ab-21

CPB-923RH 100 ul
EUR 460

Rabbit Anti-Rabbit MAP2K2 Polyclonal Antibody, Ab-394

CPB-924RH 100 ul
EUR 460

Rabbit Anti-Rabbit RELA Polyclonal Antibody, Ab-254

CPB-925RH 100 ul
EUR 460

Rabbit Anti-Rabbit PRKCQ Polyclonal Antibody, Phospho-Ser695

CPB-723RH 100 ul
EUR 559

Rabbit Anti-Rabbit CTNNB1 Polyclonal Antibody, Phospho-Ser33

CPB-758RH 100 ul
EUR 559

Rabbit Anti-Rabbit CTNNB1 Polyclonal Antibody, Phospho-Ser37

CPB-759RH 100 ul
EUR 559

Anti-Dnmt3b Rabbit Monoclonal Antibody Rabbit Monoclonal Antibody

M00319 100ug/vial
EUR 397
Description: Rabbit Monoclonal Dnmt3b Antibody Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat.

Rabbit Anti-Mouse Agouti antiserum

AGO11-S 100 ul
EUR 457

Polyclonal Rabbit Anti-DHCR7 antibody

AMR09690G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Rabbit Anti-DHCR7 . This antibody is tested and proven to work in the following applications:

Polyclonal Rabbit Anti-IFNGR2 antibody

AMR09691G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Rabbit Anti-IFNGR2 . This antibody is tested and proven to work in the following applications:

Polyclonal Rabbit Anti-STRA6 antibody

AMR09692G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Rabbit Anti-STRA6 . This antibody is tested and proven to work in the following applications:

Rabbit Anti-BSA polyclonal antibody

CABT-BL8663 1.0 mg
EUR 273

Rabbit Anti-Albumin polyclonal antibody

CABT-BL8664 1.0 mg
EUR 715

Rabbit Anti-Albumin polyclonal antibody

CABT-BL8665 1.0 mg
EUR 715

Rabbit Anti-Albumin polyclonal antibody

CABT-BL8666 1.0 mg
EUR 715

Rabbit Anti-MMAF polyclonal antibody

CABT-L3102 100 uL
EUR 1167

Rabbit Anti-Calicheamicin polyclonal antibody

CABT-L3106 100 uL
EUR 1500

Rabbit Anti-Duocarmycin polyclonal antibody

CABT-L3108 100 uL
EUR 1500

Rabbit Anti-Amanitin polyclonal antibody

CABT-L3112 100 uL
EUR 1375

Rabbit Anti-SN38 polyclonal antibody

CABT-L3114 100 uL
EUR 1375

Rabbit Anti-E2 Polyclonal antibody

CABT-RM212 1 mg
EUR 910

Rabbit Anti-E2 Polyclonal antibody

CABT-RM213 1 mg
EUR 910

Rabbit Anti-Bovine Casein IgG

CASN11-SB 100 ug
EUR 445

Rabbit Anti-bovine Catalase antiserum

CATB11-S 100 ul
EUR 432

Rabbit anti-Human CD40 antiserum

CD4011-S 100 ul
EUR 457

Rabbit Anti-LRP6 Monoclonal Antibody

CAB-3806RH 100 ul
EUR 840

The MSDS can be used to transfer documented data to databases such as e.g. the register of the German company MS or REGIMS. The MSDS has already been successfully implemented in clinical practice and is currently being evaluated in a multi-center environment. High quality management and documentation are essential to improve clinical practice and research.